Nanomedicine Market Research Reports & Industry Analysis
The idea that pharmaceutical agents should be delivered specifically to diseased cells holds the promise of a variety of benefits. The promise of individualized medicine is that it is efficient. Targeted drug-delivery allows doctors and patients to benefit from small dosages at just the right place and thus from fewer side effects.
Nanoparticles could be used to help fight disease. Tiny nanoparticles could be launched into tumors and heated up using light to destroy cancer cells. This could help treat cancers, which are inoperable and resistant to chemotherapy.
Nanorobots are nanodevices that will be used for the purpose of maintaining and protecting the human body against pathogens. Metabolizing local glucose, oxygen and other sources within the body for energy, can source the power of nanorobots. These nanorobots will be able to distinguish between different cell types by checking their surface antigens.
Nanomedicine has therapeutic uses as well. Nanotechnology is capable of delivering medication to the exact location where they are needed, hence lesser side effects. It can also be used to destroy harmful organisms or cancer cells by interrupting their division process. Nanoprobes can be made to generate radiation that could kill bacteria, viruses and cancer cells. Nanotechnology also theoretically allows the mimicking of natural biological processes, e.g. repair of damaged tissues or acting as artificial red blood cells to transport oxygen.
Nanomedicine Industry Research & Market Reports
-
Nanotechnology
... 2030, growing at a CAGR of 10.8% over the period 2022-2030. Nanocomposites, one of the segments analyzed in the report, is projected to record 10.4% CAGR and reach US$71.8 Billion by the end of the ... Read More
-
Coatings for Medical Devices
... to reach a revised size of US$21.7 Billion by 2030, growing at a CAGR of 8.5% over the period 2022-2030. Anti-Microbial, one of the segments analyzed in the report, is projected to record 9% CAGR ... Read More
-
RNAi Drug Delivery: Technologies and Global Markets
... encapsulation are divided into polymers, lipids and others (e.g., inorganic material, hybrid systems). The market is also segmented based on the molecule types, delivery modes and therapeutic areas. It is divided by application types into ... Read More
-
Global Healthcare Nanomedicine Market Growth (Status and Outlook) 2023-2029
... in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Healthcare Nanomedicine is forecast to a readjusted size of US$ 392850 million by 2029 with a CAGR of 10.4% during review ... Read More
-
Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2032
... is expected to reach USD 537.75 billion by 2032, according to a new study by Polaris Market Research. The report “Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical ... Read More
-
Global Nanomedicine Market is segmented based on Indication, Drug Delivery System, Product, Application, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
... Bn in 2023 and is expected to reach USD 406.67 Bn by 2028, growing at a CAGR of 13.14%. The use of nanotechnology in medicine and healthcare is referred to as nanomedicine. It includes the ... Read More
-
Post-pandemic Healthcare Business Models in APAC—2023
... for innovative business models. Several challenges, such as personnel burnout, the lack of experienced staff, inflation leading to increased care costs, healthcare accessibility disparities, and the rise of chronic diseases and aging population, are significant ... Read More
-
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems
... and diagnostics as well as analyses of global market trends, using 2022 as the base year and forecasting market sizes for 2023 through 2028 with compound annual growth rate (CAGR) projections. The report includes an ... Read More
-
Nanomedicine Market Outlook and Forecasts 2023 – 2030
... purposes. It offers tremendous potential in revolutionizing diagnostics, drug delivery, imaging, and therapeutics, with the aim of improving patient outcomes and addressing unmet medical needs. The global nanomedicine market is experiencing significant growth and is ... Read More
-
Global Nanomedicine Market Assessment, By Nanomolecule Type [Nanoparticles (Polymer-Based, Lipid-Based, Nanocrystals, Inorganic, others), Nanoshells, Nanodevices, Nanotubes], By Application [Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others], By Disease Indication [Oncological Diseases, Infectious Diseases, Orthopaedic Diseases, Cardiovascular Diseases, Others], By Region, Opportunities, and Forecast 2016-2030F
... Diseases, Cardiovascular Diseases, Others], By Region, Opportunities, and Forecast 2016-2030F Global Nanomedicine Market size was valued at USD 168.4 billion in 2022 which is expected to reach USD 319.72 billion in 2030 growing with a ... Read More
-
Nanotechnology Drug Delivery Market By Formulation (Lipid-based nanomedicine, Polymer-based nanomedicine, Nanocrystals, Others), By Application (Oncology and Hematology, Infectious diseases, Orthopedics, Neurology, Urology, Immunology, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... delivery market was valued for $87.5 billion in 2022 and is estimated to reach $209.5 billion by 2032, exhibiting a CAGR of 9.1% from 2023 to 2032. Nanotechnology is a scientific field that involves manipulating ... Read More
-
Nanoparticle Formulation Market: Technologies and Services, 2023-2035
... growth rate (CAGR) of 10.5% during the forecast period. Over the years, nanoparticles have emerged as a versatile drug delivery system for the controlled, targeted delivery of therapeutics for the treatment of several diseases. Owing ... Read More
-
Global Nanomaterial Based Adjuvants Vaccine Market Research Report 2023(Status and Outlook)
... North America is the largest market, with a share about 60%, followed by Europe and Japan with the share about 20% and 5%. In terms of product, Lipidosome is the largest segment, with a share ... Read More
-
Global Embolization Particle Market to 2027
... a tumour in a logical order to diminish it or in readiness for total abolition. Few embolised particles or tiny materials are forcefully injected into the clinic's patients' critical veins during the advanced process known ... Read More
-
Global Nanomedicine Market Report and Forecast 2023-2031
... of 12.2% during the forecast period of 2023-2031 to attain a value of USD 677.7 billion by 2031. Nanomedicine Market: Introduction Nanomedicine refers to the application of nanotechnology in the field of healthcare and medicine. ... Read More
-
France Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Summary GlobalData’s “France Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
-
United States of America (USA) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... and Forecast to 2030 Summary GlobalData’s “United States Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United States Embolization Particle Procedures. The databook report provides procedure ... Read More
-
China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Summary GlobalData’s “China Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
-
Russia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Summary GlobalData’s “Russia Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
-
Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Summary GlobalData’s “Australia Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
-
India Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Summary GlobalData’s “India Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
-
South Korea Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterin
... 2030 Summary GlobalData’s “South Korea Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the South Korea Embolization Particle Procedures. The databook report provides procedure volumes within segments ... Read More
-
Asia-Pacific (APAC) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
... 2030 Summary GlobalData’s “Asia-Pacific Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Asia-Pacific Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization ... Read More
-
Spain Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibr
... Summary GlobalData’s “Spain Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
-
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Summary GlobalData’s “Mexico Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
Research Assistance
